Twirla® is an innovative birth control patch developed by Agile Therapeutics, designed to provide an effective and convenient contraceptive option for women of reproductive potential with a Body Mass Index (BMI) under 30 kg/m². This transdermal system releases a combination of levonorgestrel and ethinyl estradiol, offering a low-dose hormonal solution ideal for busy lifestyles where remembering a daily pill can be challenging.

Twirla is a weekly patch, making it easy to integrate into various routines without invasive procedures. However, it's important to note that Twirla may not be appropriate for women with a BMI of 30 kg/m² or higher or those with certain medical histories, including smoking and cardiovascular issues.

To support women in their contraceptive journey, Agile Therapeutics provides educational resources, guidance on discussing options with healthcare providers, and connections to telehealth services. Through Twirla, users gain access to a reliable and straightforward birth control method designed with their needs in mind.